The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...
The Mexican boxer's preparation continues ahead of his fight against Wiliam Scull. Saul "Canelo" Alvarez is not one to mince words and if he is challenged, he himself is the one who raises the ...